Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1976 Jun 5;1(6022):1373–1376. doi: 10.1136/bmj.1.6022.1373

Comparison of intra-amniotic prostaglandin F2 alpha and hypertonic saline for induction of second-trimester abortion.

PMCID: PMC1640129  PMID: 1276696

Abstract

The efficacy and safety of intra-amniotic prostaglandin (PG) F2 alpha (25 mg repeated in six hours) and hypertonic saline (200 ml 20% NaC1) were compared in an international multicentre randomised study organised by the World Health Organisation's prostaglandin task force. Both hypertonic saline and PGF2alpha were found to be effective in terminating second-trimester pregnancy. The main advantage of PGF2alpha however, was its greater efficacy, with significantly higher success rates in the first 48 hours. Out of 717 women given PGF2alpha 614 (85-6%) aborted within 48 hours; by 24 hours 439 (61-2%) had aborted, and by 36 hours 574 (80-1%) had aborted. Out of 796 women given hypertonic saline 641 (80-5%) aborted within 48 hours; however, by 24 and 36 hours, respectively, only 161 (20-2%) and 462 (58%) had aborted. Although PGF2alpha was associated with a somewhat higher frequency of minor side effects than hypertonic saline, notably vomiting and diarrhoea, these were within acceptable limits. Only 59 women (8-2%) in the prostaglandin group had more than four episodes of vomiting and 11 (1-5%) more than four episodes of diarrhoea. Ohter side effects occurred only occasionally. No difference was found between the two groups in the frequency of incomplete abortion or excessive bleeding.

Full text

PDF
1375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amy J. J., Karim S. M., Sivasamboo R. Intra-amniotic administration of prostaglandin 15 (S) 15-methyl-E2 methyl ester for termination of pregnancy. J Obstet Gynaecol Br Commonw. 1973 Nov;80(11):1017–1020. doi: 10.1111/j.1471-0528.1973.tb02968.x. [DOI] [PubMed] [Google Scholar]
  2. Anderson G. G., Hobbins J. C., Rajkovic V., Goldstein L., Speroff L., Caldwell B. V. Midtrimester therapeutic abortion using intraamniotic PGF2alpha. Adv Biosci. 1973;9:539–543. [PubMed] [Google Scholar]
  3. Ballard C. A., Quilligan E. J. Intraamniotic prostaglandin F2alpha for midtrimester abortion. Adv Biosci. 1973;9:551–554. [PubMed] [Google Scholar]
  4. Bradley-Watson P. J., Beard R. J., Craft I. L. Injuries of the cervix after induced midtrimester abortion. J Obstet Gynaecol Br Commonw. 1973 Mar;80(3):284–285. doi: 10.1111/j.1471-0528.1973.tb02201.x. [DOI] [PubMed] [Google Scholar]
  5. Bygdeman M., Beguin F., Toppozada M., Wiqvist N. Intrauterine administration of prostaglandin F2alpha for induction of abortion. Adv Biosci. 1973;9:525–531. [PubMed] [Google Scholar]
  6. Corlett R. C., Jr, Ballard C. A. The induction of midtrimester abortion with intra-amniotic prostaglandin F2alpha. A single-dose technique. Am J Obstet Gynecol. 1974 Feb 1;118(3):353–357. doi: 10.1016/s0002-9378(16)33792-9. [DOI] [PubMed] [Google Scholar]
  7. Craft I. Letter: Prostaglandins and convulsions. Lancet. 1973 Dec 15;2(7842):1389–1389. doi: 10.1016/s0140-6736(73)93355-2. [DOI] [PubMed] [Google Scholar]
  8. Fraser I. S., Gray C. Letter: Electroencephalogram changes after prostaglandin. Lancet. 1974 Mar 2;1(7853):360–360. doi: 10.1016/s0140-6736(74)93118-3. [DOI] [PubMed] [Google Scholar]
  9. Gréen K., Bygdeman M., Wiqvist N. Kinetic and metabolic studies of Prostaglandin F2-alpha administered intra-amniotically for induction of abortion. Life Sci. 1974 Jun 1;14(11):2285–2297. doi: 10.1016/0024-3205(74)90110-6. [DOI] [PubMed] [Google Scholar]
  10. Kajanoja P., Jungner G., Widholm O., Karjalainen O., Seppälä M. Rupture of the cervix in prostaglandin abortions. J Obstet Gynaecol Br Commonw. 1974 Mar;81(3):242–244. doi: 10.1111/j.1471-0528.1974.tb00452.x. [DOI] [PubMed] [Google Scholar]
  11. Karim S. M., Sharma S. D. Second trimester abortion with single intra-amniotic injection of prostaglandins E2 or F2 alpha. Lancet. 1971 Jul 3;2(7714):47–48. doi: 10.1016/s0140-6736(71)90035-3. [DOI] [PubMed] [Google Scholar]
  12. Lauersen N. H., Wilson K. H. Midtrimester abortion induced with a single intra-amniotic instillation of prostaglandin F2 alpha. Am J Obstet Gynecol. 1974 Jan 15;118(2):210–217. doi: 10.1016/0002-9378(74)90551-1. [DOI] [PubMed] [Google Scholar]
  13. Lyneham R. C., Low P. A., McLeod J. C., Shearman R. P., Smith I. D., Korda A. R. Convulsions and electroencephalogram abnormalities after intra-amniotic prostaglandin F2a. Lancet. 1973 Nov 3;302(7836):1003–1005. doi: 10.1016/s0140-6736(73)91094-5. [DOI] [PubMed] [Google Scholar]
  14. MacKenzie I. Z., Hillier K., Embrey M. P. Letter: Convulsions and prostaglandin-induced abortion. Lancet. 1973 Dec 8;2(7841):1323–1323. doi: 10.1016/s0140-6736(73)92895-x. [DOI] [PubMed] [Google Scholar]
  15. Nyberg R. Therapeutic abortion by intraamniotic administration of prostaglandin F2alpha. Adv Biosci. 1973;9:533–537. [PubMed] [Google Scholar]
  16. Roberts G., Gomersall R., Adams M., Turnbull A. C. Therapeutic abortion by intraamniotic injection of prostaglandins. Adv Biosci. 1973;9:555–560. [PubMed] [Google Scholar]
  17. Seppälä M., Kajanoja P., Widholm O., Vara P. Prostaglandin-oxytocin abortion: a clinical trial of intra-amniotic prostaglandin F2alpha in combination with intravenous oxytocin. Prostaglandins. 1972 Oct;2(4):311–319. doi: 10.1016/s0090-6980(72)80018-2. [DOI] [PubMed] [Google Scholar]
  18. Shearman R., Smith I., Korda A. Second trimester termination by intra-uterine prostaglandin F 2 . Clinical and hormonal results with observations on induced lactation and chronoperiodicity. J Reprod Med. 1972 Dec;9(6):448–452. [PubMed] [Google Scholar]
  19. Wentz A. C., Burnett L. S., Atienza M. F., King T. M. Experience with intra-amniotic prostaglandin F2 alpha for abortion. Am J Obstet Gynecol. 1973 Oct 15;117(4):513–521. doi: 10.1016/0002-9378(73)90113-0. [DOI] [PubMed] [Google Scholar]
  20. Wentz A. C., Thompson B. H., King T. M. Posterior cervical rupture following prostaglandin-induced mid-trimester abortion. Am J Obstet Gynecol. 1973 Apr 15;115(8):1107–1110. doi: 10.1016/0002-9378(73)90560-7. [DOI] [PubMed] [Google Scholar]
  21. Wiqvist N., Bygdeman M., Toppozada M. Intra-aminotic prostaglandin administration-a challenge to the currently used methods for induction of midtrimester abortion. Contraception. 1973 Aug;8(2):113–131. doi: 10.1016/0010-7824(73)90119-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES